GANX - CIK 0001819411
Gain Therapeutics, Inc. (GANX) reported revenue of $55.18K for fiscal year 2023, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2023 | $55.18K | -60.6% |
| FY 2022 | $140.11K | -15.1% |
| FY 2021 | $164.99K | +471.3% |
| FY 2020 | $28.88K | - |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.